Skip to content

Cardiac Normal Values Assessed by Magnetic Resonance Imaging

A Multicenter Investigation of Cardiac Normal Values of Morphology, Function and Tissue Characteristics by Magnetic Resonance Imaging

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05346094
Enrollment
938
Registered
2022-04-26
Start date
2022-01-01
Completion date
2027-06-30
Last updated
2023-01-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Participants, Reference Values

Keywords

reference values, morphology, function, tissue characterization, myocardial deformation, cardiocascular magnetic resonance imaging

Brief summary

This study carried out a study enrolled healthy volunteers to comprehensively provide age and sex specific reference values of the normal cardiac structure and function of Chinese adults, using the steady-state free precession technique (SSFP) as well as reference values for novel cardiovascular magnetic resonance techniques including myocardial strian and tissue characterization.

Detailed description

Cardiovascular magnetic resonance (CMR), as a non-invasive and radiation-free examination, can identify the structural and functional abnormalities of various cardiovascular diseases. It is the gold standard for cardiovascular structural and functional measurements, and recommended as a priority examination for cardiovascular diseases by guidelines of the American College of Cardiology (ACC/AHA) and the European College of Cardiology (ESC). The reference standard for cardiovascular structure and function of normal people is the basis for cardiovascular disease study, and plays a vital role in diagnosis, differential diagnosis, and prognosis evaluation. CMR parameters have been shown to provide significant information for the general population and have always been important biomarkers for morbidity and mortality in patients with cardiac pathologies. Although there are relevant reference standards for normal values in the world, there is no standard for normal values of large samples of Chinese people. In addition, most of the normal values are limited to traditional parameters of cardiac structure and function, and there is no normal value standard for novel parameters including myocardial strain and tissue characteristics. Therefore, on the basis of previous works, our group planned to create a cardiovascular MRI reference value database of normal Chinese people through retrospective and prospective recruitment, which will lay a foundation for the early identification and prognosis assessment of cardiovascular diseases, and promote the progress of systematic cardiovascular magnetic resonance studies.

Interventions

OTHERNo intervention

No intervention

Sponsors

Chinese Academy of Medical Sciences, Fuwai Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
No minimum to 80 Years
Healthy volunteers
Yes

Inclusion criteria

Subjects without cardiovascular disease, cardiovascular related symptoms and risk factors judged by combining clinical manifestations, non-invasive imaging and laboratory examination

Exclusion criteria

* Subjects clinically screened or previously diagnosed with cardiovascular disease and risk factors * Subjects with serious non-cardiovascular diseases * Subjects with poor quality of magnetic resonance imaging * Subjects refused to participate in the study * Subjects with contraindications to MRI

Design outcomes

Primary

MeasureTime frameDescription
Normal values of left and right structures and cardiac function5 yearsCreate a database for normal values of left and right structures and cardiac function
Normal values of novel cardiovascular magnetic resonance parameters5 yearsCreate a database for normal values of novel cardiovascular magnetic resonance parameters

Countries

China

Contacts

Primary ContactMinjie Lu
coolkan@163.com13681042022
Backup ContactBaiyan Zhuang
zbyan10@163.com+8613661168732

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026